Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation. The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of progressive multiple sclerosis treatment programs require individualized development, typically including pharmacotherapy, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many diseases of the nervous system that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the disease.
Multidisciplinary collaboration (MDT) is especially important for the integrated management of progressive multiple sclerosis. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.